close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

Home・Aandelen Lijst・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Gesloten

SectorGezondheidszorg

15.04 0.47

Buy

Prijsupdate 3 feb 2026, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.78

Max

15.33

Belangrijke statistieken

By Trading Economics

Inkomsten

28M

8.2M

Verkoop

351K

351K

K/W

Sectorgemiddelde

17.761

90.422

EPS

0.94

Winstmarge

2,337.322

Werknemers

103

EBITDA

28M

9.3M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+45.21% upside

Dividenden

By Dow Jones

Volgende Winsten

12 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

8M

141M

Vorige openingsprijs

14.57

Vorige sluitingsprijs

15.04

Nieuwssentiment

By Acuity

34%

66%

95 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

N/A / 9.31 Steun & Weerstand

Seres Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 feb 2026, 23:11 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

DJ

Lezen

3 feb 2026, 23:50 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

3 feb 2026, 23:50 UTC

Marktinformatie

Nikkei May Decline After Hitting All-Time High -- Market Talk

DJ

Lezen

3 feb 2026, 23:42 UTC

Marktinformatie

Gold Edges Lower on Possible Technical Correction -- Market Talk

DJ

Lezen

3 feb 2026, 23:41 UTC

Acquisities, Fusies, Overnames

KKR Makes AI Play With $10.9B Asia Data-Center Deal

DJ

Lezen

3 feb 2026, 23:38 UTC

Winsten

AMD Sales Climb on Help From Data-Center Business -- Update

DJ

Lezen

3 feb 2026, 23:29 UTC

Acquisities, Fusies, Overnames

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

DJ

Lezen

3 feb 2026, 23:27 UTC

Acquisities, Fusies, Overnames

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

DJ

Lezen

3 feb 2026, 23:25 UTC

Acquisities, Fusies, Overnames

KKR-Consortium Expects Deal to Close by Early 2H of 2026

DJ

Lezen

3 feb 2026, 23:23 UTC

Acquisities, Fusies, Overnames

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

DJ

Lezen

3 feb 2026, 23:22 UTC

Acquisities, Fusies, Overnames

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

DJ

Lezen

3 feb 2026, 23:19 UTC

Marktinformatie

Australia Gold Miners Tipped to Rally Higher -- Market Talk

DJ

Lezen

3 feb 2026, 23:19 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

3 feb 2026, 22:56 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

DJ

Lezen

3 feb 2026, 22:40 UTC

Winsten

Amdocs Extends Collaboration With T-Mobile

DJ

Lezen

3 feb 2026, 22:39 UTC

Winsten

Amdocs 1Q Adj EPS $1.81

DJ

Lezen

3 feb 2026, 22:39 UTC

Winsten

Amdocs 1Q Rev $1.16B

DJ

Lezen

3 feb 2026, 22:39 UTC

Winsten

Amdocs 1Q EPS $1.45 >

DJ

Lezen

3 feb 2026, 22:38 UTC

Winsten

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

DJ

Lezen

3 feb 2026, 22:30 UTC

Acquisities, Fusies, Overnames

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

DJ

Lezen

3 feb 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

DJ

Lezen

3 feb 2026, 22:14 UTC

Winsten

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

DJ

Lezen

3 feb 2026, 22:13 UTC

Winsten

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

DJ

Lezen

3 feb 2026, 22:12 UTC

Winsten

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

DJ

Lezen

3 feb 2026, 22:10 UTC

Winsten

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

DJ

Lezen

3 feb 2026, 22:10 UTC

Winsten

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

DJ

Lezen

3 feb 2026, 22:10 UTC

Marktinformatie

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

DJ

Lezen

3 feb 2026, 22:10 UTC

Winsten

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

DJ

Lezen

3 feb 2026, 22:09 UTC

Winsten

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

DJ

Lezen

3 feb 2026, 22:09 UTC

Winsten

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

DJ

Lezen

Peer Vergelijking

Prijswijziging

Seres Therapeutics Inc Prognose

Koersdoel

By TipRanks

45.21% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD  45.21%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Seres Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Seres Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

N/A / 9.31Steun & Weerstand

Korte Termijn

Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

95 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

JNJ

Johnson and Johnson

233.01

↑ +1.03%

UNH

UnitedHealth Group Inc

284.01

↓-0.6%

TMO

Thermo Fisher Scientific Inc

568.43

↓-2.07%

ABT

Abbott Laboratories

108.96

↓-0.46%

ISRG

Intuitive Surgical Inc

478.71

↓-3.54%
help-icon Live chat